Received: 7 July 2021
Accepted: 21 December 2021
First Online: 6 January 2022
: The study was approved from the institute research board of Faculty of Medicine, Zagazig University, Egypt (ZU-IRB#7007/23-6-2020). A written informed consent was obtained from all the participants or their responsible relatives (if the patient was unable to provide consent due to disturbed conscious level or weakness) after informing them about the study rationale and their right to withdraw from the study at any time without any consequences.
: All participants had signed an informed consent to participate and for the data to be published.
: The authors declare that they have no competing interests.